000			02020cam a2200313 4500
020			_a9241207752
035			_a(Sirsi) 9241207752
060			_aWM 270
110	1		_aWHO Expert Committee on Drug Dependence.
242	1	0	_aComité OMS d' experts de la pharmacodépendance [réuni à Genève, 18-23 avril 1988] : _bvingt-cinquième rapport
242	1	0	_aComité de Expertos de la OMS en Farmacodependencia [se reunió en Ginebra del 18 al 23 de abril de 1988] : _b25 informe
245	0	0	_aWHO Expert Committee on Drug Dependence [meeting held in Geneva from 18 to 23 April 1988] : _btwenty-fifth report.
260			_aGeneva : _bWorld Health Organization, _c1989.
300			_a48 p.
440		0	_aWorld Health Organization technical report series ; _vno. 775
520	3		_aConveys the views and recommendations of an expert committee commissioned to assess selected narcotic drugs and psychotropic substances and to determine which should be recommended for control under existing international treaties. Evaluations and recommendations are presented for 14 substances in the categories of sedative-hypnotics, opioid agonist-antagonist analgesics, and stimulants. Recommendations for scheduling or descheduling are based on ratings of therapeutic usefulness as well as the potential for abuse. For the opioid agonist-antagonist analgesics, the report provides a general explanation of criteria for scheduling, including a discussion of mechanisms of pharmacologic actions that influence drug-seeking behaviour and dependence and form the basis of the committees evaluations.
546			_achi eng fre rus spa.
550			_aWHODOC
561			_aWHO monograph
596			_a4
650	0	2	_aSubstance-related disorders.
690			_aAlcoholism and Drug Abuse.
710	2		_aWorld Health Organization.
856			_uhttps://apps.who.int/iris/
856			_uhttps://apps.who.int/iris/
856			_uhttps://apps.who.int/iris/
008			890210s1989 eng
942			_2NLM _cMONOGRAPH
999			_c12502 _d12502